Global CT Equipment Procedure Volumes and Reimbursement Growth Opportunities

Global CT Equipment Procedure Volumes and Reimbursement Growth Opportunities

Demand for Pulmonary and Abdomen-based Imaging Accelerating the Growth of CT Procedures

RELEASE DATE
24-Jan-2022
REGION
North America
Research Code: PCB2-01-00-00-00
SKU: HC03492-NA-MT_26201
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC03492-NA-MT_26201

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restraining factors for operational efficiency and workflows. However, CT remains an indispensable tool in diagnosing and managing illness. For COVID-19, CT scans offer the broadest diagnostic window with promising clinical imaging for initial diagnosis and post-recovery outcomes. The CT industry is dynamic and involves many players that introduce technological innovations to match the rapidly evolving needs of clinicians, radiologists, and technologists. Innovations in CT, including spectral imaging, photon counting (to lower radiation dosage) with new detector materials, wide-area detector, and reconstruction algorithms for multi-detector CT technology, are expected to drive the market toward faster upgrades and equipment replacement. Most developed economies (North America, Western Europe, Japan, and Australia) have a CT penetration level of over 80% in their healthcare sectors. As CT is an indispensable tool for screening, intervention, and therapy planning, tertiary care hospitals liaise with secondary care facilities to handle patient volumes. Globally, the CT market is witnessing a gradual transition from low-end CT scanners to mid-high and high-end scanners. The shift toward high-end scanners is primarily due to the innovations in CT technology to reduce radiation dosage and expand clinical applications in vascular, oncology, cardiac, and breast cancer imaging. Revenue growth of high-end CT scanners will be primarily driven by purchases from large tertiary and university hospital segments in North America, Western Europe, and Japan. The proportion of shipments to diagnostic imaging centers and practices are increasing with 16- to 64-slice scanners, embarking on a path of moderate growth over the forecast period. Favorable reimbursement trends for procedures and the proportion of patients enrolling in private health insurance schemes will propel market growth further. The pandemic led to cancellations or postponements of elective surgeries, taking a toll on patient traffic in radiology and affecting CT modalities with a decrease of 20%–25% in procedural volumes in 2020. As economies move toward recovery, healthcare systems report a gradual increase in elective surgeries and are stepping up efforts to address the accumulated backlog at varying capacities. The continued demand for procedures coupled with new CT capacity purchases/replacement sales will bolster growth throughout the forecast period. Global markets are expected to return to pre-COVID-19 business performance levels between 2024 and 2025 from economic recovery and COVID-19 recovery rates.

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Computed Tomography (CT) Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Key Highlights

Research Scope

Segmentation and Life Cycle Analysis

Revenue and Unit Shipment Forecast

Percent Revenue and Unit Shipment by Region

Mid-high Scanners and Replacement of Low-end Scanners Drive Growth Trends

Estimated Competitor Market Share

Growth Drivers

Growth Restraints

Estimated Procedures by Anatomy

Estimated Procedures by Geography

Hospital Landscape and CT Equipment Infrastructure—United States

Healthcare Insurance and Reimbursement Trends—United States

CT Reimbursement for Chest and Heart—United States

Hospital Landscape and CT Equipment Infrastructure—Germany

Healthcare Insurance and Reimbursement Trends—Germany

CT Reimbursement for Chest and Heart—Germany

Hospital Landscape and CT Equipment Infrastructure—France

Healthcare Insurance and Reimbursement Trends—France

CT Reimbursement for Chest and Heart—France

Hospital Landscape and CT Equipment Infrastructure—Italy

Healthcare Insurance and Reimbursement Trends—Italy

CT Reimbursement for Chest and Heart—Italy

Hospital Landscape and CT Equipment Infrastructure—Spain

Healthcare Insurance and Reimbursement Trends —Spain

CT Reimbursement for Chest and Heart—Spain

Hospital Landscape and CT Equipment Infrastructure—United Kingdom

Healthcare Insurance and Reimbursement Trends—United Kingdom

CT Reimbursement for Chest and Heart—United Kingdom

2020 CT Reimbursement Summary

Growth Opportunity 1—Population-based Screening Programs for New Clinical Applications Will Improve CT Volumes

Growth Opportunity 1—Population-based Screening Programs for New Clinical Applications Will Improve CT Volumes (continued)

Growth Opportunity 2—CT Penetration in Cardiac Centers, Particularly Coronary CT Angiography (CCTA) and Fractional Flow Reserve (FFR) Procedures, Will Accelerate Market Growth

Growth Opportunity 2—CT Penetration in Cardiac Centers, Particularly Coronary CT Angiography (CCTA) and Fractional Flow Reserve (FFR) Procedures Will Accelerate Market Growth (continued)

Growth Opportunity 3—Emergence of Technologies such as Photon Counting Will Create a New Market in Computed Tomography

Growth Opportunity 3—Emergence of Technologies such as Photon Counting Will Create a New Market in Computed Tomography (continued)

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing at 3% to 4% every year. While the COVID-19 pandemic in 2020 led to a drop in CT procedures by over 20%, the industry is expected to be completely functional by the end of 2021. Pandemic-based sanitization protocols and patient hesitancy remain restraining factors for operational efficiency and workflows. However, CT remains an indispensable tool in diagnosing and managing illness. For COVID-19, CT scans offer the broadest diagnostic window with promising clinical imaging for initial diagnosis and post-recovery outcomes. The CT industry is dynamic and involves many players that introduce technological innovations to match the rapidly evolving needs of clinicians, radiologists, and technologists. Innovations in CT, including spectral imaging, photon counting (to lower radiation dosage) with new detector materials, wide-area detector, and reconstruction algorithms for multi-detector CT technology, are expected to drive the market toward faster upgrades and equipment replacement. Most developed economies (North America, Western Europe, Japan, and Australia) have a CT penetration level of over 80% in their healthcare sectors. As CT is an indispensable tool for screening, intervention, and therapy planning, tertiary care hospitals liaise with secondary care facilities to handle patient volumes. Globally, the CT market is witnessing a gradual transition from low-end CT scanners to mid-high and high-end scanners. The shift toward high-end scanners is primarily due to the innovations in CT technology to reduce radiation dosage and expand clinical applications in vascular, oncology, cardiac, and breast cancer imaging. Revenue growth of high-end CT scanners will be primarily driven by purchases from large tertiary and university hospital segments in North America, Western Europe, and Japan. The proportion of shipments to diagnostic imaging centers and practices are increasing with 16- to 64-slice scanners, embarking on a path of moderate growth over the forecast period. Favorable reimbursement trends for procedures and the proportion of patients enrolling in private health insurance schemes will propel market growth further. The pandemic led to cancellations or postponements of elective surgeries, taking a toll on patient traffic in radiology and affecting CT modalities with a decrease of 20%–25% in procedural volumes in 2020. As economies move toward recovery, healthcare systems report a gradual increase in elective surgeries and are stepping up efforts to address the accumulated backlog at varying capacities. The continued demand for procedures coupled with new CT capacity purchases/replacement sales will bolster growth throughout the forecast period. Global markets are expected to return to pre-COVID-19 business performance levels between 2024 and 2025 from economic recovery and COVID-19 recovery rates.
More Information
No Index No
Podcast No
Author Poornima Srinivasan
Industries Healthcare
WIP Number PCB2-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9566-B1,9570-B1,9614-B1